-+ 0.00%
-+ 0.00%
-+ 0.00%

Standard BioTools risks Nasdaq delisting after shares stay below $1 bid price rule

PUBT·04/24/2026 20:16:40
Listen to the news
Standard BioTools risks Nasdaq delisting after shares stay below $1 bid price rule
  • Standard BioTools received a Nasdaq notice on April 20, 2026 for failing to meet minimum $1 bid price requirement on Nasdaq Global Select Market.
  • Stock remains listed and trading under ticker LAB, with no immediate impact on operations or SEC reporting.
  • Company has until Oct. 19, 2026 to regain compliance by closing at or above $1 for at least 10 consecutive business days.
  • Nasdaq may grant an additional 180-day cure period if LAB transfers listing to Nasdaq Capital Market, with reverse split cited as a potential remedy.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Standard BioTools Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-177290), on April 24, 2026, and is solely responsible for the information contained therein.